Surg-27. stereotactic laser ablation (sla) as treatment for brain metastases that recur after stereotactic radiosurgery: a multi-institutional experience

CONCLUSION:SLA is an effective treatment option for BMs that fail SRS. Ablation of >80% of BMs is associated with decreased risk of disease progression. The efficacy of SLA in this setting may be augmented by adjuvant hypo-fractionated SRS.

Source: Neuro-Oncology - November 6, 2016 Category: Cancer & Oncology Authors: Chen, C., Amaan, M., Rennert, R., Carroll, K., Sharma, M., Barnholtz-sloan, J., Myers, C., Barnett, G., Smith, K., Mohammadi, A., Sloan, A. Tags: SURGICAL THERAPY Source Type: research